The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer

The development of third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) targeting T790M-mutant non-small cell lung cancer (NSCLC) has raised the importance of re-biopsy after EGFR-TKI failure. This study aimed to investigate the feasibility of interventional pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wen-Chien, Shen, Yi-Cheng, Chen, Chieh-Lung, Liao, Wei-Chih, Chen, Hung-Jen, Hsia, Te-Chun, Chen, Chia-Hung, Tu, Chih-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819002/
https://www.ncbi.nlm.nih.gov/pubmed/36611420
http://dx.doi.org/10.3390/diagnostics13010129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819002/
https://www.ncbi.nlm.nih.gov/pubmed/36611420
http://dx.doi.org/10.3390/diagnostics13010129

Ejemplares similares